Heinrich Dreismann, Director at MYRIAD GENETICS INC (MYGN), sold 10,000 shares at $27.05 ($271K) on 2024-09-09, disclosed to the SEC on 2024-09-09.
Open-market sale of $270k MYGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| MYGN | SELL | 2014-02-20 | $1.1M | — | Filing → |
| MYGN | SELL | 2013-05-10 | $935K | — | Filing → |